Koukourakis, Michael I <br/><br/>
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2009 
 - 7069-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-0688  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Biopsy<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--drug therapy<br/>Combined Modality Therapy--methods<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>RNA, Messenger--metabolism<br/>Radiation-Sensitizing Agents--therapeutic use<br/>Radiotherapy--methods<br/>Radiotherapy, Conformal--methods<br/>Treatment Outcome